Marie Ooi

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Carfilzomib is an irreversible proteasome inhibitor and is an effective treatment for multiple myeloma (MM). 1,2 It received US Food and Drug Administration approval based on a single-arm multicenter trial of carfilzomib monotherapy in 266 patients with relapsed MM following at least two prior lines of treatment including bortezomib and immunomodulators.(More)
BACKGROUND AND STUDY AIMS Endoscopist-Directed Nurse-Administered Propofol Sedation (EDNAPS) has been evaluated in community settings rather than tertiary referral centers. PATIENTS AND METHODS A hospital-wide prospectively collected database of Medical Emergency Team Calls (METCALL), emergency responses triggered by medically unstable patients, was(More)
  • 1